[MATRIX] QoQ Cumulative Quarter Result on 31-Mar-2024 [#4]

Stock
[MATRIX] MATRIX CONCEPTS HOLDINGS BHD
Announcement Date
27-May-2024
Admission Sponsor
-
Sponsor
-
Financial Year
31-Mar-2024
Quarter
31-Mar-2024 [#4]
Profit Trend
QoQ- 32.6%
YoY- 18.19%
Quarter Report
Latest QR
Upcoming QR
MATRIX's Result
MATRIX's Financial Summary
View:
Show?
Cumulative Result
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Revenue 600,755 279,715 1,339,896 986,759 690,780 331,426 1,117,624 -33.81%
PBT 171,166 81,083 334,055 247,160 171,035 87,222 273,290 -26.73%
Tax -41,303 -19,584 -85,943 -63,682 -44,224 -23,518 -69,160 -29.01%
NP 129,863 61,499 248,112 183,478 126,811 63,704 204,130 -25.96%
-
NP to SH 128,112 60,691 246,472 185,870 128,632 64,602 208,535 -27.66%
-
Tax Rate 24.13% 24.15% 25.73% 25.77% 25.86% 26.96% 25.31% -
Total Cost 470,892 218,216 1,091,784 803,281 563,969 267,722 913,494 -35.63%
-
Net Worth 2,176,903 2,152,319 2,114,779 2,089,751 2,064,725 2,027,184 1,989,644 6.16%
Dividend
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Div 65,682 31,283 125,134 93,851 62,567 31,283 115,749 -31.38%
Div Payout % 51.27% 51.55% 50.77% 50.49% 48.64% 48.43% 55.51% -
Equity
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Net Worth 2,176,903 2,152,319 2,114,779 2,089,751 2,064,725 2,027,184 1,989,644 6.16%
NOSH 1,251,093 1,251,348 1,251,348 1,251,348 1,251,348 1,251,348 1,251,348 -0.01%
Ratio Analysis
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
NP Margin 21.62% 21.99% 18.52% 18.59% 18.36% 19.22% 18.26% -
ROE 5.89% 2.82% 11.65% 8.89% 6.23% 3.19% 10.48% -
Per Share
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
RPS 48.02 22.35 107.08 78.86 55.20 26.49 89.31 -33.80%
EPS 10.24 4.85 19.70 14.85 10.28 5.16 16.66 -27.64%
DPS 5.25 2.50 10.00 7.50 5.00 2.50 9.25 -31.37%
NAPS 1.74 1.72 1.69 1.67 1.65 1.62 1.59 6.17%
Adjusted Per Share Value based on latest NOSH - 1,251,348
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
RPS 48.03 22.36 107.12 78.89 55.23 26.50 89.35 -33.81%
EPS 10.24 4.85 19.70 14.86 10.28 5.16 16.67 -27.67%
DPS 5.25 2.50 10.00 7.50 5.00 2.50 9.25 -31.37%
NAPS 1.7404 1.7207 1.6907 1.6707 1.6507 1.6207 1.5907 6.16%
Price Multiplier on Financial Quarter End Date
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Date 30/09/24 28/06/24 29/03/24 29/12/23 29/09/23 30/06/23 31/03/23 -
Price 2.00 1.78 1.80 1.65 1.49 1.41 1.45 -
P/RPS 4.17 7.96 1.68 2.09 2.70 5.32 1.62 87.49%
P/EPS 19.53 36.70 9.14 11.11 14.49 27.31 8.70 71.19%
EY 5.12 2.72 10.94 9.00 6.90 3.66 11.49 -41.57%
DY 2.63 1.40 5.56 4.55 3.36 1.77 6.38 -44.52%
P/NAPS 1.15 1.03 1.07 0.99 0.90 0.87 0.91 16.83%
Price Multiplier on Announcement Date
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Date 26/11/24 22/08/24 27/05/24 23/02/24 23/11/23 22/08/23 24/05/23 -
Price 2.24 1.89 1.82 1.79 1.61 1.47 1.43 -
P/RPS 4.66 8.46 1.70 2.27 2.92 5.55 1.60 103.54%
P/EPS 21.88 38.97 9.24 12.05 15.66 28.47 8.58 86.33%
EY 4.57 2.57 10.82 8.30 6.38 3.51 11.65 -46.32%
DY 2.34 1.32 5.49 4.19 3.11 1.70 6.47 -49.14%
P/NAPS 1.29 1.10 1.08 1.07 0.98 0.91 0.90 27.04%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment